Those who were TET2‐CHIP+/AgeAccelHG+ and with no alternate alleles of rs2228145 (IL6RWT) had the highest risk for the composite mortality/CHD outcome relative to the referent group of CHIP−/AgeAccelHG−/IL6RWT (HR =11.3, p < 2.4 × 10−21, Figure S6). This evidence concerns the gene TET2 and coronary artery disorder.